These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 17116036

  • 1. How to replace lamotrigine with valproate.
    Steinhoff BJ.
    Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
    [Abstract] [Full Text] [Related]

  • 2. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
    Kim HJ, Kim TE, Joo EY, Seo DW, Lee SY, Hong SB.
    Clin Chim Acta; 2015 Jan 01; 438():269-73. PubMed ID: 25218785
    [Abstract] [Full Text] [Related]

  • 3. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ, Fakhoury TA, Kustra RP, Vuong A, Hammer AE, Messenheimer JA.
    Curr Med Res Opin; 2007 Oct 01; 23(10):2461-5. PubMed ID: 17727739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients.
    Wen D, Chen Z, Yang C, Liu H, Li H, Chen J, Dai Q, Zhong G, Qin J, Ni G, Huang M, Zhou L, Wang X.
    J Pharm Biomed Anal; 2018 Feb 05; 149():448-456. PubMed ID: 29169113
    [Abstract] [Full Text] [Related]

  • 6. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction.
    Kanner AM, Frey M.
    Neurology; 2000 Aug 22; 55(4):588-91. PubMed ID: 10953201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A.
    Epilepsia; 2004 Sep 22; 45(9):1049-53. PubMed ID: 15329068
    [Abstract] [Full Text] [Related]

  • 9. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use.
    Herzog AG, Blum AS, Farina EL, Maestri XE, Newman J, Garcia E, Krishnamurthy KB, Hoch DB, Replansky S, Fowler KM, Smithson SD, Dworetzky BA, Bromfield EB.
    Neurology; 2009 Mar 10; 72(10):911-4. PubMed ID: 19273825
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R, Brodie MJ.
    Epilepsy Behav; 2005 May 10; 6(3):382-7. PubMed ID: 15820347
    [Abstract] [Full Text] [Related]

  • 11. Clinical study of lamotrigine and valproic acid in patients with epilepsy: using a drug interaction to advantage?
    Morris RG, Black AB, Lam E, Westley IS.
    Ther Drug Monit; 2000 Dec 10; 22(6):656-60. PubMed ID: 11128232
    [Abstract] [Full Text] [Related]

  • 12. A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.
    Knoester PD, Deckers CL, Termeer EH, Boendermaker AJ, Kotsopoulos IA, de Krom MC, Keyser T, Renier WO, Hekster YA, Severens HL.
    Value Health; 2007 Dec 10; 10(3):173-82. PubMed ID: 17532810
    [Abstract] [Full Text] [Related]

  • 13. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K, Wang X, Xi Z, Yan Y.
    Clin Neurol Neurosurg; 2010 May 10; 112(4):291-5. PubMed ID: 20071075
    [Abstract] [Full Text] [Related]

  • 14. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
    Stephen LJ, Sills GJ, Leach JP, Butler E, Parker P, Hitiris N, Leach VM, Wilson EA, Brodie MJ.
    Epilepsy Res; 2007 Jul 10; 75(2-3):122-9. PubMed ID: 17553671
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
    Gidal BE, Sheth R, Parnell J, Maloney K, Sale M.
    Epilepsy Res; 2003 Dec 10; 57(2-3):85-93. PubMed ID: 15013050
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A.
    Epilepsia; 1999 Aug 10; 40(8):1141-6. PubMed ID: 10448829
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS, Hoppu K, Nergårdh A, Boreus L.
    Epilepsia; 1996 Aug 10; 37(8):769-73. PubMed ID: 8764817
    [Abstract] [Full Text] [Related]

  • 18. The Effectiveness of Lamotrigine and Its Blood Levels for Pediatric Epilepsy.
    Iwasaki T, Toki T, Nonoda Y, Ishii M.
    Am J Ther; 2017 Aug 10; 24(5):e524-e531. PubMed ID: 26295614
    [Abstract] [Full Text] [Related]

  • 19. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI, No SK, Yi SD, Lee HW, Kim OJ, Kim SH, Kim MK, Kim SE, Kim YS, Kim JM, Lee SJ, Shin DJ, Park SP, Kim YI, Heo K, Cho YW, Cho YJ, Kim YN.
    Seizure; 2018 Feb 10; 55():17-24. PubMed ID: 29324401
    [Abstract] [Full Text] [Related]

  • 20. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
    Tompson DJ, Ali I, Oliver-Willwong R, Job S, Zhu L, Lemme F, Hammer AE, Vuong A, Messenheimer JA.
    Epilepsia; 2008 Mar 10; 49(3):410-7. PubMed ID: 17825077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.